Streetbeat News

Analyst Ratings

PTEN

Analysts have diverse opinions on Patterson-UTI Energy (NASDAQ:PTEN), with recent evaluations ranging from bullish to bearish. The average 12-month price target is now $16.00, down from $16.64, reflecting a 3.85% decline. Analysts from firms like Evercore ISI Group, B of A Securities, Susquehanna, RBC Capital, and Raymond James have adjusted their ratings and price targets, indicating a cautious outlook on PTEN's performance. Despite a significant revenue growth rate of 100.93% as of December 31, 2023, concerns about profitability and efficiency metrics such as net margin, ROE, and ROA suggest challenges ahead.

Portfolio Pulse from Benzinga Insights

May 03, 2024 | 8:00 pm

NSIT

Insight Enterprises (NASDAQ:NSIT) has received mixed analyst ratings over the last three months, with a shift towards a more neutral stance in the last 30 days. The average 12-month price target for NSIT has been raised to $202.17, indicating a positive sentiment shift. Analysts from JP Morgan and Barrington Research have adjusted their ratings and price targets, reflecting changes in market dynamics and company performance. Despite facing revenue decline and debt management challenges, Insight Enterprises boasts a strong net margin, ROE, and ROA, outperforming industry standards.

Portfolio Pulse from Benzinga Insights

May 03, 2024 | 8:00 pm

CDE

Coeur Mining (NYSE:CDE) has received mixed analyst ratings over the last three months, with a recent shift towards a more bullish outlook. The average 12-month price target for CDE has been raised to $4.58, indicating an 18.04% increase from the previous target. Analysts from BMO Capital and Raymond James have adjusted their price targets and ratings, reflecting updated market conditions and company performance. Coeur Mining, a precious metals producer, has shown a notable revenue growth rate of 24.74% as of December 31, 2023, but faces challenges in profitability and debt management.

Portfolio Pulse from Benzinga Insights

May 03, 2024 | 8:00 pm

TRUP

Recent analyst ratings for Trupanion (NASDAQ:TRUP) show a predominantly neutral outlook, with a shift towards a more cautious stance in the last three months. Five analysts have updated their ratings, resulting in one somewhat bullish and four indifferent positions. The average 12-month price target for TRUP has been adjusted to $28.2, down from $30.60, indicating a 7.84% decrease. Analyst actions include both lowered and raised price targets, reflecting responses to market dynamics and company performance. Trupanion's financials reveal a 20.26% revenue growth rate but below-average profitability and efficiency metrics.

Portfolio Pulse from Benzinga Insights

May 03, 2024 | 8:00 pm

GMAB

HC Wainwright & Co. analyst Raghuram Selvaraju has reiterated a Buy rating on Genmab (NASDAQ:GMAB) and maintained a $50 price target.

Portfolio Pulse from Benzinga Newsdesk

May 03, 2024 | 7:59 pm

SCLX

HC Wainwright & Co. analyst Raghuram Selvaraju maintains a Buy rating on Scilex Holding (NASDAQ:SCLX) but lowers the price target from $12 to $8.

Portfolio Pulse from Benzinga Newsdesk

May 03, 2024 | 7:57 pm

LIFE

HC Wainwright & Co. analyst Joseph Pantginis reiterates a Buy rating on aTyr Pharma (NASDAQ:LIFE) and maintains a $35 price target.

Portfolio Pulse from Benzinga Newsdesk

May 03, 2024 | 7:55 pm

KURA

HC Wainwright & Co. analyst Joseph Pantginis reiterates a Buy rating on Kura Oncology (NASDAQ:KURA) with a maintained price target of $32.

Portfolio Pulse from Benzinga Newsdesk

May 03, 2024 | 7:53 pm

W

Wayfair's stock price increased following price target upgrades from multiple analysts.

Portfolio Pulse from Benzinga Newsdesk

May 03, 2024 | 7:49 pm

BMEA

HC Wainwright & Co. analyst Joseph Pantginis reiterated a Buy rating on Biomea Fusion (NASDAQ:BMEA) and maintained a $50 price target.

Portfolio Pulse from Benzinga Newsdesk

May 03, 2024 | 7:49 pm